Date Added: Apr 2011
A University of Notre Dame entrepreneurial team developing a nanocomposite bone substitute claimed the $30,000 top prize March 25 in the inaugural Nanotechnology New Ventures Competition, sponsored by Purdue University and the University of Notre Dame. Citrics Biomedical, led by Notre Dame graduate A.J. Noronha and Matthew Vaughn, won for its business plan presentation on its biocompatible, bioresorbable nanocomposite product called CitrOSponge, which is designed to facilitate bone healing and aid in hard-tissue regeneration. The venture is housed in Innovation Park, a research park wholly owned by Notre Dame that seeks to help build commercialization bridges between the University of Notre Dame and businesses at all stages of development, from startups through established regional firms and Fortune 500 companies.